ZDA
FLXN

Zweig-DiMenna Associates’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Zweig-DiMenna Associates’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-84,683
Closed -$1.06M – 129
2019
Q1 		$1.06M Sell
84,683
-18,324
-18% -$245K 0.12% 90
2018
Q4 		$1.17M Sell
103,007
-120,000
-54% -$1.88M 0.12% 94
2018
Q3 		$4.17M Hold
223,007
– – 0.36% 84
2018
Q2 		$5.76M Buy
+223,007
New +$5.79M 0.47% 83
2018
Q1 		– Sell
-131,505
Closed -$3.29M – 185
2017
Q4 		$3.29M Buy
+131,505
New +$3.22M 0.41% 73
2017
Q3 		– Sell
-186,880
Closed -$3.78M – 252
2017
Q2 		$3.78M Buy
+186,880
New +$3.89M 0.28% 97

Other funds holding FLXN

MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
KCM
Kingdon Capital Management New York $597M AUM 51.11% 1-Year Est. Return